SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                                              Commission File Number:  000-29057

                           NOTIFICATION OF LATE FILING

          (Check One):   [ ] Form 10-K    [ ] Form 11-K    [ ] Form 20F

                         [X] Form 10-Q    [ ]  Form N-SAR

          For Period Ended:      September 30, 2003
                                 ------------------

[ ]  Transition Report on Form 10-K         [ ]  Transition Report on Form 10-Q

[ ]  Transition Report on Form 20-F         [ ]  Transition Report on Form N-SAR

[ ]  Transition Report on Form 11-K

     For the Transition Period Ended:
                                     -------------------------------------------

    READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.

     Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:
                                                       -------------------------
--------------------------------------------------------------------------------

                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant:            Altrimega Health Corporation /d/b/a Creative
                                    Holding & Marketing Corp.
                                    --------------------------------------------

Former name if applicable:          N/A
                                    ---

Address of principal executive
office (Street and number):         4702 Oleander Drive, Suite 200
                                    ------------------------------
City, state and zip code:           Myrtle Beach, South Carolina
                                    ------------------------------


                                     PART II
                             RULE 12b-25 (b) AND (c)

     If the subject  report could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.)

[X]  (a) The reasons  described  in  reasonable  detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

[X]  (b) The subject annual report,  semi-annual  report,  transition  report on
     Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
     before the 15th  calendar day  following  the  prescribed  due date; or the
     subject  quarterly  report or  transition  report on Form 10-Q,  or portion
     thereof  will be filed on or before the fifth  calendar day  following  the
     prescribed due date; and

[ ]  (c) The accountant's  statement or other exhibit required by Rule 12b-25(c)
     has been attached if applicable.



                                                                     FORM 12b-25


                                    PART III
                                    NARRATIVE

     State below in  reasonable  detail the reasons why Form 10-K,  11-K,  10-Q,
N-SAR or the  transition  report  portion  thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)

     Due to unforeseeable  circumstances,  which caused a delay in preparing the
quarterly  statements  for the period ended  September 30, 2003,  the Registrant
respectfully requests an extension of the filing date of its Quarterly Report on
Form 10-QSB for the period ended September 30, 2003.


                                     PART IV
                                OTHER INFORMATION

     1.   Name and  telephone  number of  person  to  contact  in regard to this
notification:
          John W. Gandy          (843)               497-7028
          -----------------------------------------------------------
             (Name)           (Area code)        (Telephone number)

     2.   Have all other periodic reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment  Registrant
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                       [X] Yes        [ ] No

     3.   Is it anticipated that any significant change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                       [ ] Yes        [X] No

     If so: attach an explanation of the anticipated  change,  both  narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

                                       2


                                                                     FORM 12b-25


                          ALTRIMEGA HEALTH CORPORATION
                          ----------------------------
                  (Name of registrant as specified in charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.



Date:  November 14, 2003                              By:  /s/ John W. Gandy
                                                           ---------------------
                                                               John W. Gandy
                                                               President

          INSTRUCTION.  The form may be signed by an  executive  officer  of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

                                    ATTENTION

     Intentional  misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

     1.   This  form is  required  by  Rule  12b-25  of the  General  Rules  and
Regulations under the Securities Exchange Act of 1934.

     2.   One  signed  original  and  four  confirmed  copies  of this  form and
amendments  thereto must be completed and filed with the Securities and Exchange
Commission,  Washington,  DC 20549,  in accordance  with Rule 0-3 of the General
Rules and Regulations under the Act. The information  contained in or filed with
the form will be made a matter of the public record in the Commission files.

     3.   A manually  signed copy of the form and  amendments  thereto  shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

     4.   Amendments to the notifications  must also be filed on Form 12b-25 but
need not restate information that has been correctly  furnished.  The form shall
be clearly identified as an amended notification.

     5.   ELECTRONIC  FILERS.  This form shall not be used by electronic  filers
unable to timely file a report  solely due to  electronic  difficulties.  Filers
unable to submit a report within the time period  prescribed due to difficulties
in  electronic  filing  should  comply  with  either  Rule  201 or  Rule  202 of
Regulation  S-T or apply for an adjustment in filing date pursuant to Rule 13(b)
of Regulation S-T.

                                       3